Inducible rodent models of acquired podocyte diseases

American Journal of Physiology - Renal Physiology

Volumn 296, Issue 2, 2009, Pages

  Pippin, Jeffrey W ^a   Brinkkoetter, Paul T ^a   Cormack Aboud, Fionnualla C ^a   Durvasula, Raghu V ^a   Hauser, Peter V ^a   Kowalewska, Jolanta ^b   Krofft, Ronald D ^a   Logar, Christine M ^a   Marshall, Caroline B ^a   Ohse, Takamoto ^a   Shankland, Stuart J ^a,b  

^a Division of Nephrology   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Animal models; Glomerulus

Indexed keywords

GLOMERULOPATHY; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION; HEMODYNAMICS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; REVIEW;

EID: 60549083305     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90421.2008     Document Type: Review

References (186)

1. Abid O, Sun Q, Sugimoto K, Mercan D, Vincent JL. Predictive value of microalbuminuria in medical ICU patients: results of a pilot study. Chest 120: 1984-1988, 2001.
2. Addis T. The mechanism of proteinuria. Proc Natl Acad Sci USA 35: 194-198, 1949.
3. Adler S, Baker PJ, Pritzl P, Couser WG. Detection of terminal complement components in experimental immune glomerular injury. Kidney Int 26: 830-837, 1984.
4. Anderson MS, Recant L. Fine structural alterations in the rat kidney following intraperitoneal bovine albumin. Am J Pathol 40: 555-569, 1962.
5. Andrews PM. Scanning electron microscopy of the kidney glomerular epithelium after treatment with polycations in situ and in vitro. Am J Anat 153: 291-303, 1978.
6. Asanuma K, Kim K, Oh J, Giardino L, Chabanis S, Faul C, Reiser J, Mundel P. Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner. J Clin Invest 115: 1188-1198, 2005.
7. Ashworth CT, James JA. Glomerular excretion of macromolecular substances. Electron microscopic study of rat kidney after administration of human serum albumin. Am J Pathol 39: 307-316, 1961.
8. Assmann KJ, Tangelder MM, Lange WP, Tadema TM, Koene RA. Membranous glomerulonephritis in the mouse. Kidney Int 24: 303-312, 1983.
9. Baker PJ, Ochi RF, Schulze M, Johnson RJ, Campbell C, Couser WG. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats. Am J Pathol 135: 185-194, 1989.
10. Beck H, Bonegio GB, Eisenberg W, Powell W, Cummin D, Klein B, Salant J. Towards the identification of the autoantigen in membranous nephropathy. In: American Society of Nephrology Renal Week 2007 San Francisco Nov 2007 (SA-PO401).
11. Benigni A, Gagliardini E, Remuzzi A, Corna D, Remuzzi G. Angio-tensin-converting enzyme inhibition prevents glomerular-tubule discon-nection and atrophy in passive Heymann nephritis, an effect not observed with a calcium antagonist. Am J Pathol 159: 1743-1750, 2001.
12. Benigni A, Corna D, Maffi R, Benedetti G, Zoja C, Remuzzi G. Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy. Kidney Int 54: 646-647, 1998.
13. Bertani T, Poggi A, Pozzoni R, Delaini F, Sacchi G, Thoua Y, Mecca G, Remuzzi G, Donati MB. Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest 46: 16-23, 1982.
14. Bertani T, Cutillo F, Zoja C, Broggini M, Remuzzi G. Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 30: 488-496, 1986.
15. Blau EB, Michael AF. Rat glomerular glycoprotein composition and metabolism in aminonucleoside nephrosis. Proc Soc Exp Biol Med 141: 164-172, 1972.
16. Blau EB, Haas JE. Glomerular sialic acid and proteinuria in human renal disease. Lab Invest 28: 477-481, 1973.
17. Blume C, Heise G, Mühlfeld A, Bach D, Schrör K, Gerhardz CD, Grabensee B, Heering P. Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive Heymann nephritis in the rat. Kidney Int 56: 1770-1778, 1999.
18. Bondeva T, Roger T, Wolf G. Differential regulation of Toll-like receptor 4 gene expression in renal cells by angiotensin II: dependency on AP1 and PU.1 transcriptional sites. Am J Nephrol 27: 308-314, 2007.
19. Breiteneder-Geleff S, Matsui K, Soleiman A, Meraner P, Poczewski H, Kalt R, Schaffner G, Kerjaschki D. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol 151: 1141-1152, 1997.
20. Brewer DB, Filip O. The morphometry of the glomerular epithelial cell and its foot processes after the injection of bovine serum albumin or egg albumin. J Pathol 120: 209-220, 1976.
21. Camussi G. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease. J Immunol 136:2127-2135, 1986.
22. Caulfield JP, Farquhar MG. The permeability of glomerular capillaries of aminonucleoside nephrotic rats to graded dextrans. J Exp Med 142:61-83, 1975.
23. Caulfield JP, Farquhar MG. Loss of anionic sites from the glomerular basement membrane in aminonucleoside nephrosis. Lab Invest 39: 505-512, 1978.
24. Caulfield JP, Reid JJ, Farquhar MG. Alterations of the glomerular epithelium in acute aminonucleoside nephrosis. Evidence for formation of occluding junctions and epithelial cell detachment. Lab Invest 34:43-59, 1976.
25. Charest PM, Roth J. Localization of sialic acid in kidney glomeruli: regionalization in the podocyte plasma membrane and loss in experimental nephrosis. Proc Natl Acad Sci USA 82: 8508-8512, 1985.
26. Chen A, Sheu LF, Ho YS, Lin YF, Chou WY, Chou TC, Lee WH. Experimental focal segmental glomerulosclerosis in mice. Nephron 78:440-452, 1998.
27. Chen A, Wei CH, Sheu LF, Ding SL, Lee WH. Induction of proteinuria by adriamycin or bovine serum albumin in the mouse. Nephron 69:293-300, 1995.
28. Chen JS, Chen A, Chang LC, Chang WWS, Lee HS, Lin SH, Lin YF. Mouse model of membranous nephropathy induced by cationic bovine serum albumin: Antigen dose-response relations and strain differences. Nephrol Dial Transplant 19: 2721-2728, 2004.
29. Cheng ZZ, Pätäri A, Aalto-Setälä K, Novikov D, Schlöndorff D, Holthöfer H. Hypercholesterolemia is a prerequisite for puromycin inducible damage in mouse kidney. Kidney Int 63: 107-112, 2003.
30. Cosyns JP, Kazatchkine MD, Bhakdi S, Mandet C, Grossetete J, Hinglais N, Bariety J. Immunohistochemical analysis of C3 cleavage fragments, factor H, and the c5b-9 terminal complex of complement in de novo membranous glomerulonephritis occurring in patients with renal transplant. Clin Nephrol 26: 203-208, 1986.
31. Couser WG. Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 11: 449-464, 1988.
32. Cunningham PN, Hack BK, Ren G, Minto AW, Morgan BP, Quigg RJ. Glomerular complement regulation is overwhelmed in passive Hey-mann nephritis. Kidney Int 60: 900-909, 2001.
33. Cybulsky AV, Quigg RJ, Salant DJ. The membrane attack complex in complement-mediated glomerular epithelial cell injury: formation and stability of c5b-9 and c5b-7 in rat membranous nephropathy. J Immunol 137: 1511-1516, 1986.
34. Cybulsky AV, Rennke HG, Feintzeig ID, Salant DJ. Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy. J Clin Invest 77: 1096-1107, 1986.
35. Cybulsky AV, Quigg RJ, Salant DJ. Experimental membranous nephropathy redux. Am J Physiol Renal Physiol 289: F660-F671, 2005.
36. Davies DJ, Messina A, Thumwood CM, Ryan GB. Glomerular podo-cytic injury in protein overload proteinuria. Pathology 17: 412-419, 1985.
37. Davies DJ, Brewer DB, Hardwicke J. Urinary proteins and glomerular morphometry in protein overload proteinuria. Lab Invest 38: 232-243, 1978.
38. De Boer E, Navis G, Tiebosch AT, De Jong PE, De Zeeuw D. Systemic factors are involved in the pathogenesis of proteinuria-induced glomerulosclerosis in adriamycin nephrotic rats. J Am Soc Nephrol 10: 2359-2366, 1999.
39. Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann J, Bens-man A, Deschênes G, Ronco PM. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 346:2053-2060, 2002.
40. Deman A, Ceyssens B, Pauwels M, Zhang J, Houte KV, Verbeelen D, Van den Branden C. Altered antioxidant defence in a mouse adriamycin model of glomerulosclerosis. Nephrol Dial Transplant 16: 147-150, 2001.
41. Derr RF, Alexander CS, Nagasawa HT. Metabolism of puromycin aminonucleoside in the normal, "pre-nephrotic," and nephrotic rat. Proc Soc Exp Biol Med 125: 248 -252, 1967.
42. Diamond JR, Bonventre JV, Karnovsky MJ. A role for oxygen free radicals in aminonucleoside nephrosis. Kidney Int 29: 478 -483, 1986.
43. Diamond JR, Karnovsky MJ. Focal and segmental glomerulosclerosis following a single intravenous dose of puromycin aminonucleoside. Am J Pathol 122: 481-487, 1986.
44. Donadelli R, Zanchi C, Morigi M, Buelli S, Batani C, Tomasoni S, Corna D, Rottoli D, Benigni A, Abbate M, Remuzzi G, Zoja C. Protein overload induces fractalkine upregulation in proximal tubular cells through nuclear factor kappaB- and p38 mitogen-activated protein kinase-dependent pathways. J Am Soc Nephrol 14: 2436-2446, 2003.
45. Eddy AA, Kim H, López-Guisa J, Oda T, Soloway PD. Interstitial fibrosis in mice with overload proteinuria: deficiency of TIMP-1 is not protective. Kidney Int 58: 618-628, 2000.
46. Eddy AA. Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 135: 719-733, 1989.
47. Edgington TS, Glassock RJ, Watson JI, Dixon FJ. Characterization and isolation of specific renal tubular epithelial antigens. J Immunol 99:1199 -1210, 1967.
48. Edgington TS, Glassock RJ, Dixon FJ. Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med 127: 555-572, 1968.
49. Endo M, Fuke Y, Tamano M, Hidaka M, Ohsawa I, Fujita T, Ohi H. Glomerular deposition and urinary excretion of complement factor H in idiopathic membranous nephropathy. Nephron Clin Pract 97: c147-c153, 2004.
50. Faas M, Bakker W, Poelman R, Schuiling G. Pregnancy aggravates proteinuria in subclinical glomerulonephritis in the rat. J Lab Clin Med 134: 267-274, 1999.
51. Farquhar MG, Vernier RL, Good RA. An electron microscope study of the glomerulus in nephrosis, glomerulonephritis, and lupus erythematosus. J Exp Med 106: 649-660, 1957.
52. Farquhar MG, Palade GE. Glomerular permeability. II. Ferritin transfer across the glomerular capillary wall in nephrotic rats. J Exp Med 114: 699-716, 1961.
53. Farquhar MG, Saito A, Kerjaschki D, Orlando RA. The Heymann nephritis antigenic complex: megalin (gp330) and RAP. J Am Soc Nephrol 6: 35-47, 1995.
54. Faul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol 17: 428-437, 2007.
55. Feenstra K, Lee RVD, Greben HA, Arends A, Hoedemaeker PJ. Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. I. The natural history: a histologic and immunohistologic study at the light microscopic and the ultrastructural level. Lab Invest 32: 235-242, 1975.
56. Feldman JD, Fisher ER. Renal lesions of aminonucleoside nephrosis as revealed by electron microscopy. Lab Invest 8: 371-385, 1959.
57. Fiegleson EB, Drake JW, Recant L. Experimental aminonucleoside nephrosis in rats. J Lab Clin Med 50: 437-446, 1957.
58. Filipiak WE, Saunders TL. Advances in transgenic rat production. Transgenic Res 15: 673-686, 2006.
59. Fogo A, Yoshida Y, Glick AD, Homma T, Ichikawa I. Serial mi-cropuncture analysis of glomerular function in two rat models of glomerular sclerosis. J Clin Invest 82: 322-330, 1988.
60. Frenk S, Antonowicz I, Craig JM, Metcoff J. Experimental nephrotic syndrome induced in rats by aminonucleoside; renal lesions and body electrolyte composition. Proc Soc Exp Biol Med 89: 424-427, 1955.
61. Frenk S. Aminonucleoside-induced nephropathy. Curr Contents 36:51-52, 1993.
62. Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57: 727-741, 1999.
63. Glasser RJ, Velosa JA, Michael AF. Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis. Lab Invest 36: 519-526, 1977.
64. Grond J, Weening JJ, Elema JD. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and amino-nucleoside. Lab Invest 51: 277-285, 1984.
65. Guan N, Ding J, Deng J, Zhang J, Yang J. Key molecular events in puromycin aminonucleoside nephrosis rats. Pathol Int 54: 703-711, 2004.
66. Hahn H, Park YS, Ha IS, Cheong HI, Choi Y. Age-Related differences in adriamycin-induced nephropathy. Pediatr Nephrol 19: 761-766, 2004.
67. Harkin JC, Recant L. Pathogenesis of experimental nephrosis electron microscopic observations. Am J Pathol 36: 303-329, 1960.
68. Harvey SJ, Jarad G, Cunningham J, Rops AL, van der Vlag J, Berden JH, Moeller MJ, Holzman LB, Burgess RW, Miner JH. Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity. Am J Pathol 171: 139-152, 2007.
69. Heymann W, Hackel DB, Harwood S, Wilson SG, Hunter JL. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions. Proc Soc Exp Biol Med 100: 660-664, 1959.
70. Hosoyamada M, Yan K, Nishibori Y, Takiue Y, Kudo A, Kawakami H, Shibasaki T, Endou H. Nephrin and podocin expression around the onset of puromycin aminonucleoside nephrosis. J Pharmacol Sci 97: 234-241, 2005.
71. Hoyer JR, Ratte J, Potter AH, Michael AF. Transfer of aminonucleo-side nephrosis by renal transplantation. J Clin Invest 51: 2777-2780, 1972.
72. Huber TB, Benzing T. The slit diaphragm: a signaling platform to regulate podocyte function. Curr Opin Nephrol Hypertens 14: 211-216, 2005.
73. Hunsicker LG, Shearer TP, Shaffer SJ. Acute reversible proteinuria induced by infusion of the polycation hexadimethrine. Kidney Int 20:7-17, 1981.
74. Inokuchi S, Shirato I, Kobayashi N, Koide H, Tomino Y, Sakai T. Re-evaluation of foot process effacement in acute puromycin amino-nucleoside nephrosis. Kidney Int 50: 1278 -1287, 1996.
75. Ishola DA, van der Giezen DM, Hahnel B, Goldschmeding R, Kriz W, Koomans HA, Joles JA. In mice, proteinuria and renal inflammatory responses to albumin overload are strain-dependent. Nephrol Dial Transplant 21: 591-597, 2006.
76. Ji Z, Huang C, Liang C, Chen B, Chen S, Sun W. Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis. Cell Mol Immunol 2: 150-154, 2005.
77. Karnovsky MJ, Ryan GB. Substructure of the glomerular slit diaphragm in freeze-fractured normal rat kidney. J Cell Biol 65: 233-236, 1975.
78. Kawachi H, Koike H, Kurihara H, Sakai T, Shimizu F. Cloning of rat homologue of podocin: expression in proteinuric states and in developing glomeruli. J Am Soc Nephrol 14: 46-56, 2003.
79. Kawachi H, Koike H, Kurihara H, Yaoita E, Orikasa M, Shia MA, Sakai T, Yamamoto T, Salant DJ, Shimizu F. Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states. Kidney Int 57: 1949-1961, 2000.
80. Kerjaschki D, Farquhar MG. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci USA 79: 5557-5561, 1982.
81. Kerjaschki D, Schulze M, Binder S, Kain R, Ojha PP, Susani M, Horvat R, Baker PJ, Couser WG. Transcellular transport and membrane insertion of the c5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J Immunol 143: 546-552, 1989.
82. Kerjaschki D, Vernillo AT, Farquhar MG. Reduced sialylation of podocalyxin-the major sialoprotein of the rat kidney glomerulus-in aminonucleoside nephrosis. Am J Pathol 118: 343-349, 1985.
83. Kerjaschki D, Farquhar MG. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. J Exp Med 157: 667-686, 1983.
84. Kerjaschki D. Polycation-induced dislocation of slit diaphragms and formation of cell junctions in rat kidney glomeruli: the effects of low temperature, divalent cations, colchicine, and cytochalasin B. Lab Invest 39: 430-440, 1978.
85. Kerjaschki D, Sharkey DJ, Farquhar MG. Identification and characterization of podocalyxin-the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol 98: 1591-1596, 1984.
86. Kim YH, Goyal M, Kurnit D, Wharram B, Wiggins J, Holzman L, Kershaw D, Wiggins R. Podocyte depletion and glomerulosclerosis have a direct relationship in the pan-treated rat. Kidney Int 60: 957-968, 2001.
87. Kramer A, van den Hoven M, Rops A, Wijnhoven T, van den Heuvel L, Lensen J, van Kuppevelt T, van Goor H, van der Vlag J, Navis G, Berden JH. Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system. J Am Soc Nephrol 17: 2513-2520, 2006.
88. Kubosawa H, Kondo Y. Modulation of cytoskeletal organization of podocytes during the course of aminonucleoside nephrosis in rats. Pathol Int 44: 578 -586, 1994.
89. Kurihara H, Anderson JM, Kerjaschki D, Farquhar MG. The altered glomerular filtration slits seen in puromycin aminonucleoside nephrosis and protamine sulfate-treated rats contain the tight junction protein ZO-1. Am J Pathol 141: 805-816, 1992.
90. Lai KN, Lo ST, Lai FM. Immunohistochemical study of the membrane attack complex of complement and s-protein in idiopathic and secondary membranous nephropathy. Am J Pathol 135: 469 -476, 1989.
91. Landwehr DM. Renal artery infusion of the polycation protamine and urinary albumin excretion (Abstract). Kidney Int 14: 727, 1978.
92. Lannigan R, Kark R, Pollak VE. The effect of a single intravenous injection of aminonucleoside of puromycin on the rat kidney: a light- and electron-microscope study. J Pathol Bacteriol 83: 357-362, 1962.
93. Lawrence GM, Brewer DB. Effect of strain and sex on the induction of hyperalbuminaemic proteinuria in the rat. Clin Sci (Lond) 61: 751-756, 1981.
94. Lawrence GM, Brewer DB. A biochemical and immunological investigation into the physiological basis of the increased albumin filtration induced in hyperalbuminaemic female Wistar rats. Clin Sci (Lond) 62:495-502, 1982.
95. Lebrecht D, Setzer B, Rohrbach R, Walker UA. Mitochondrial DNA and its respiratory chain products are defective in doxorubicin nephrosis. Nephrol Dial Transplant 19: 329-336, 2004.
96. Lee DBN, Huang E, Ward HJ. Tight junction biology and kidney dysfunction. Am J Physiol Renal Physiol 290: F20-F34, 2006.
97. Lemley KV. Glomerular size selectivity during protein overload in the rat. Am J Physiol Renal Fluid Electrolyte Physiol 264: F1046-F1051, 1993.
98. Lenderink AM, Liegel K, Ljubanovic D, Coleman KE, Gilkeson GS, Holers VM, Thurman JM. The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy. Am J Physiol Renal Physiol 293: F555-F564, 2007.
99. Li J, Zhou C, Yu L, Wang H. Renal protective effects of blocking the intrarenal renin-angiotensin system. Hypertens Res 22: 223-228, 1999.
100. Lippman RW, Ureen HJ, Oliver J. Mechanism of proteinuria. III. A comparison of the functional and structural aspects of the effects of certain intraperitoneally administered proteins on hemoglobin excretion in the rat. J Exp Med 93: 325-336, 1951.
101. Luimula P, Ahola H, Wang SX, Solin ML, Aaltonen P, Tikkanen I, Kerjaschki D, Holthöfer H. Nephrin in experimental glomerular disease. Kidney Int 58: 1461-1468, 2000.
102. Ly J, Alexander M, Quaggin SE. A podocentric view of nephrology. Curr Opin Nephrol Hypertens 13: 299-305, 2004.
103. Magil AB. Histogenesis of glomerular crescents. Immunohistochemical demonstration of cytokeratin in crescent cells. Am J Pathol 120: 222-229, 1985.
104. Makker SP. Evidence that the antigen of autologous immune complex glomerulonephritis of rats is a mannose-or glucose-containing glycoprotein. Proc Soc Exp Biol Med 163: 95-99, 1980.
105. Makker SP, Tramontano A. Differential capacity of anti-rap and anti-megalin antibodies to produce progressive passive Heymann nephritis-implications for the pathogenesis of idiopathic human membranous glomerulonephritis. J Pathol 210: 282-287, 2006.
106. Marks MI, McLaine PN, Drummond KN. Proteinuria in children with febrile illnesses. Arch Dis Child 45: 250-253, 1970.
107. Marshall CB, Pippin JW, Krofft RD, Shankland SJ. Puromycin aminonucleoside induces oxidant-dependent DNA damage in podocytes in vitro and in vivo. Kidney Int 70: 1962-1973, 2006.
108. Mathieson PW. Minimal change nephropathy and focal segmental glomerulosclerosis. Semin Immunopathol 29: 415-426, 2007.
109. Matsui K, Breitender-Geleff S, Soleiman A, Kowalski H, Kerjaschki D. Podoplanin, a novel 43-kda membrane protein, controls the shape of podocytes. Nephrol Dial Transplant 14, Suppl 1: 9 -11, 1999.
110. McCluskey RT. Tissue factor in crescentic glomerulonephritis. Am J Pathol 150: 787-792, 1997.
111. McLaine PN, Marks MI, Baliah T, Drummond KN. Hyperproteine-mic proteinuria induced by plasma infusion. Pediatr Res 3: 597-603, 1969.
112. Messina A, Davies DJ, Dillane PC, Ryan GB. Glomerular epithelial abnormalities associated with the onset of proteinuria in aminonucleoside nephrosis. Am J Pathol 126: 220-229, 1987.
113. Messina A, Davies DJ, Ryan GB. Protamine sulphate-induced proteinuria: the roles of glomerular injury and depletion of polyanion. J Pathol 158: 147-156, 1989.
114. Michael AF, Blau E, Vernier RL. Glomerular polyanion. Alteration in aminonucleoside nephrosis. Lab Invest 23: 649 -657, 1970.
115. Milner LS, Wei SH, Houser MT. Amelioration of glomerular injury in doxorubicin hydrochloride nephrosis by dimethylthiourea. J Lab Clin Med 118: 427-434, 1991.
116. Moeller MJ, Soofi A, Hartmann I, Hir ML, Wiggins R, Kriz W, Holzman LB. Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis. J Am Soc Nephrol 15: 61-67, 2004.
117. Monnens LA. The basal membrane of the kidney [in Dutch]. Tijdschr Kindergeneeskd 50: 121-130, 1982.
118. Nagao T, Nagamatsu T, Suzuki Y. Effect of DP-1904, a thromboxane A2 synthase inhibitor, on passive Heymann nephritis in rats. Eur J Pharmacol 316: 73-80, 1996.
119. Nagasawa HT, Swingle KF, Alexander CS. Metabolism of amino-nucleoside-8-14c in the rat and guinea pig. Biochem Pharmacol 16: 2211-2219, 1967.
120. Nagasawa Y, Takenaka M, Kaimori J, Matsuoka Y, Akagi Y, Tsujie M, Imai E, Hori M. Rapid and diverse changes of gene expression in the kidneys of protein-overload proteinuria mice detected by microarray analysis. Nephrol Dial Transplant 16: 923-931, 2001.
121. Nakatsue T, Koike H, Han GD, Suzuki K, Miyauchi N, Yuan H, Salant DJ, Gejyo F, Shimizu F, Kawachi H. Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy. Kidney Int 67: 2239-2253, 2005.
122. Nakazawa M. Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis. J Exp Med 164:1973-1987, 1986.
123. Nangaku M, Pippin J, Richardson CA, Schulze M, Young BA, Alpers CE, Gordon KL, Johnson RJ, Couser WG. Beneficial effects of systemic immunoglobulin in experimental membranous nephropathy. Kidney Int 50: 2054-2062, 1996.
124. Nangaku M, Shankland SJ, Couser WG. Cellular response to injury in membranous nephropathy. J Am Soc Nephrol 16: 1195-1204, 2005.
125. Naumovic R, Jovovic D, Basta-Jovanovic G, Miloradovic Z, Mihailovic- Stanojevic N, Aleksic T, Jovanovic D. Effects of rapamycin on active Heymann nephritis. Am J Nephrol 27: 379-389, 2007.
126. Neale T, Ullrich R, Ojha P, Poczewski H, Verhoeven AJ, Kerjaschki D. Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc Natl Acad Sci USA 90: 3645-3649, 1993.
127. Ohtsuka A, Nakatani S, Horiuchi K, Taguchi T, Murakami T. Repulsive charge mechanism serve to maintain lumens and cavities. An histochemical study of rat serosa and kidney. Ital J Anat Embryol 106, 2 Suppl 1: 379-384, 2001.
128. Okuda S, Oh Y, Tsuruda H, Onoyama K, Fujimi S, Fujishima M. Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int 29: 502-510, 1986.
129. Olson JL, Rennke HG, Venkatachalam MA. Alterations in the charge and size selectivity barrier of the glomerular filter in aminonucleoside nephrosis in rats. Lab Invest 44: 271-279, 1981.
130. Ootaka T, Suzuki M, Sudo K, Sato H, Seino J, Saito T, Yoshinaga K. Histologic localization of terminal complement complexes in renal diseases. An immunohistochemical study. Am J Clin Pathol 91: 144-151, 1989.
131. Ophascharoensuk V, Pippin JW, Gordon KL, Shankland SJ, Couser WG, Johnson RJ. Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation. Kidney Int 54: 416 -425, 1998.
132. Papagianni AA, Alexopoulos E, Leontsini M, Papadimitriou M. C5B-9 and adhesion molecules in human idiopathic membranous nephropathy. Nephrol Dial Transplant 17: 57-63, 2002.
133. Park SS, Eom YW, Choi KS. Cdc2 and cdk2 play critical roles in low dose doxorubicin-induced cell death through mitotic catastrophe but not in high dose doxorubicin-induced apoptosis. Biochem Biophys Res Commun 334:1014 -1021, 2005.
134. Perkinson DT, Baker PJ, Couser WG, Johnson RJ, Adler S. Membrane attack complex deposition in experimental glomerular injury. Am J Pathol 120: 121-128, 1985.
135. Petermann A, Floege J. Podocyte damage resulting in podocyturia: A potential diagnostic marker to assess glomerular disease activity. Nephron Clin Pract 106: c61-c66, 2007.
136. Petermann AT, Krofft R, Blonski M, Hiromura K, Vaughn M, Pichler R, Griffin S, Wada T, Pippin J, Durvasula R, Shankland SJ. Podocytes that detach in experimental membranous nephropathy are viable. Kidney Int 64: 1222-1231, 2003.
137. Pyke C, Kristensen P, Ostergaard PB, Oturai PS, R0mer J. Proteoglycan expression in the normal rat kidney. Nephron 77: 461-470, 1997.
138. Rebbaa A, Zheng X, Chou PM, Mirkin BL. Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene 22: 2805-2811, 2003.
139. Reiser J, von Gersdorff G, Loos M, Oh J, Asanuma K, Giardino L, Rastaldi MP, Calvaresi N, Watanabe H, Schwarz K, Faul C, Kretzler M, Davidson A, Sugimoto H, Kalluri R, Sharpe AH, Kreidberg JA, Mundel P. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 113: 1390-1397, 2004.
140. Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int 51: 2-15, 1997.
141. Rollason TP, Brewer DB. A scanning and transmission electron microscopic study of glomerular damage in the rat following heterologous serum albumin overload. J Pathol 134: 39 -56, 1981.
142. Ronco P, Debiec H. Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men. Semin Immunopathol 29: 445-458, 2007.
143. Ruggenenti P, Remuzzi G. The role of protein traffic in the progression of renal diseases. Annu Rev Med 51: 315-327, 2000.
144. Ryan GB, Karnovsky MJ. An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis. Kidney Int 8: 219-232, 1975.
145. Sakemi T, Ohtsuka N, Tomiyoshi Y, Morito F. Sex difference in progression of adriamycin-induced nephropathy in rats. Am J Nephrol 16: 540-547, 1996.
146. Salant DJ, Belok S, Madaio MP, Couser WG. A new role for complement in experimental membranous nephropathy in rats. J Clin Invest 66: 1339-1350, 1980.
147. Saran AM, Yuan H, Takeuchi E, McLaughlin M, Salant DJ. Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy. Kidney Int 64: 2072-2078, 2003.
148. Schneeberger EE, Levey RH, McCluskey RT, Karnovsky MJ. The isoporous substructure of the human glomerular slit diaphragm. Kidney Int 8: 48-52, 1975.
149. Seiler MW, Rennke HG, Venkatachalam MA, Cotran RS. Pathogenesis of polycation-induced alterations ("fusion") of glomerular epithelium. Lab Invest 36: 48-61, 1977.
150. Seiler MW, Venkatachalam MA, Cotran RS. Glomerular epithelium: Structural alterations induced by polycations. Science 189: 390-393, 1975.
151. Shah S. Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats. Am J Physiol Renal Fluid Electrolyte Physiol 255: F438 -F443, 1988.
152. Shah SV. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 35: 1093-1106, 1989.
153. Shankland SJ, Pippin JW, Reiser J, Mundel P. Podocytes in culture: Past, present, and future. Kidney Int 72: 489-498, 2007.
154. Shankland SJ. The podocyte's response to injury: Role in proteinuria and glomerulosclerosis. Kidney Int 69: 2131-2147, 2006.
155. Shiiki H, Sasaki Y, Nishino T, Kimura T, Kurioka H, Fujimoto S, Dohi K. Cell proliferation and apoptosis of the glomerular epithelial cells in rats with puromycin aminonucleoside nephrosis. Pathobiology 66: 221-229, 1998.
156. Smoyer WE, Mundel P, Gupta A, Welsh MJ. Podocyte α-actinin induction precedes foot process effacement in experimental nephrotic syndrome. Am J Physiol Renal Physiol 273: F150-F157, 1997.
157. Song H, Li X, Zhu C, Wei M. Glomerulosclerosis in adriamycin-induced nephrosis is accelerated by a lipid-rich diet. Pediatr Nephrol 15:196 -200, 2000.
158. Sonnenburg-Hatzopoulos C, Assel E, Schurek HJ, Stolte H. Glomerular albumin leakage and morphology after neutralization of polyanions. II. Discrepancy of protamine induced albuminuria and fine structure of the glomerular filtration barrier. J Submicrosc Cytol 16: 741-751, 1984.
159. Spicer ST, Tran GT, Killingsworth MC, Carter N, Power DA, Paizis K, Boyd R, Hodgkinson SJ, Ball BM. Induction of passive Heymann nephritis in complement component 6-deficient PVG rats. J Immunol 179: 172-178, 2007.
160. Sternberg SS. Cross-striated fibrils and other ultrastructural alterations in glomeruli of rats with daunomycin nephrosis. Lab Invest 23: 39 -51, 1970.
161. Susani M, Schulze M, Exner M, Kerjaschki D. Antibodies to glyco-lipids activate complement and promote proteinuria in passive Heymann nephritis. Am J Pathol 144: 807-819, 1994.
162. Suzuki Y, Lopez-Franco O, Gomez-Garre D, Tejera N, Gomez-Guerrero C, Sugaya T, Bernal R, Blanco J, Ortega L, Egido J. Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in at1-deficient mice: role of endothelin-1. Am J Pathol 159:1895-1904, 2001.
163. Thakur V, Walker PD, Shah SV. Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria. Kidney Int 34: 494-499, 1988.
164. Thorner PS, Ho M, Eremina V, Sado Y, Quaggin S. Podocytes contribute to the formation of glomerular crescents. J Am Soc Nephrol 19: 495-502, 2008.
165. Turnberg D, Lewis M, Moss J, Xu Y, Botto M, Cook HT. Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice. J Immunol 177: 4094 -4102, 2006.
166. Vehaskari VM, Root ER, Germuth FG, Robson AM. Glomerular charge and urinary protein excretion: effects of systemic and intrarenal polycation infusion in the rat. Kidney Int 22: 127-135, 1982.
167. Venkatachalam MA, Cotran RS, Karnovsky MJ. An ultrastructural study of glomerular permeability in aminonucleoside nephrosis using catalase as a tracer protein. J Exp Med 132: 1168-1180, 1970.
168. Venkatachalam MA, Karnovsky MJ, Cotran RS. Glomerular permeability. Ultrastructural studies in experimental nephrosis using horseradish peroxidase as a tracer. J Exp Med 130: 381-399, 1969.
169. Vernier RL, Papermaster BW, Good RA. Aminonucleoside nephrosis. I. Electron microscopic study of the renal lesion in rats. J Exp Med 109:115-126, 1959.
170. Vielhauer V, Berning E, Eis V, Kretzler M, Segerer S, Strutz F, Horuk R, Gröne HJ, Schlöndorff D, Anders HJ. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. Kidney Int 66: 2264 -2278, 2004.
171. Wang Y, Wang YP, Tay YC, Harris DC. Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events. Kidney Int 58: 1797-1804, 2000.
172. + cells in the progression of murine adriamycin nephropathy. Kidney Int 59: 941-949, 2001.
173. + T cells aggravates glomerular and interstitial injury in murine adriamycin nephropathy. Kidney Int 59:975-984, 2001.
174. Weening JJ, Guldener CV, Daha MR, Klar N, Wal AVD, Prins FA. The pathophysiology of protein-overload proteinuria. Am J Pathol 129:64-73, 1987.
175. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman LB, Wiggins RC. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16: 2941-2952, 2005.
176. Whiteside C, Prutis K, Cameron R, Thompson J. Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in adriamycin and puromycin nephrosis. Lab Invest 61: 650-660, 1989.
177. Whiteside CI, Cameron R, Munk S, Levy J. Podocytic cytoskeletal disaggregation and basement-membrane detachment in puromycin ami-nonucleoside nephrosis. Am J Pathol 142: 1641-1653, 1993.
178. Wilson KHS, McIndoe RA, Eckenrode S, Morel L, Agarwal A, Croker BP, She JX. Alterations of renal phenotype and gene expression profiles due to protein overload in nod-related mouse strains. BMC Nephrol 6: 17, 2005.
179. Wilson SG, Hackel DB, Horwood S, Nash G, Heymann W. Amino-nucleoside nephrosis in rats. Pediatrics 21: 963-973, 1958.
180. Wu H, Wang Y, Tay YC, Zheng G, Zhang C, Alexander SI, Harris DCH. DNA vaccination with naked DNA encoding MCP-1 and RANTES protects against renal injury in adriamycin nephropathy. Kidney Int 67: 2178-2186, 2005.
181. Yilmaz S, Atessahin A, Sahna E, Karahan I, Ozer S. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicology 218: 164-171, 2006.
182. Yoshioka T, Rennke HG, Salant DJ, Deen WM, Ichikawa I. Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: a study in early passive Heymann nephritis. Circ Res 61: 531-538, 1987.
183. Zheng Z, Pavlidis P, Chua S, D'Agati VD, Gharavi AG. An ancestral haplotype defines susceptibility to doxorubicin nephropathy in the laboratory mouse. J Am Soc Nephrol 17: 1796-1800, 2006.
184. Zheng Z, Schmidt-Ott KM, Chua S, Foster KA, Frankel RZ, Pavlidis P, Barasch J, D'Agati VD, Gharavi AG. A Mendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse. Proc Natl Acad Sci USA 102: 2502-2507, 2005.
185. Zhou D, Ohno N, Terada N, Li Z, Morita H, Inui K, Yoshimura A, Ohno S. Immunohistochemical analyses on serum proteins in nephrons of protein-overload mice by "in vivo cryotechnique." Histol Histopathol 22: 137-145, 2007.
186. Zoja C, Benigni A, Verroust P, Ronco P, Bertani T, Remuzzi G. Indomethacin reduces proteinuria in passive Heymann nephritis in rats. Kidney Int 31: 1335-1343, 1987.